logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

 


IsoRay (ISR) Spikes Again on Announcement of Presentations at Weekend Conference

By  +Follow April 1, 2014 6:16AM
Share:
Tickers Mentioned:

Shares in small-cap health care company IsoRay (ISR) took off again on Tuesday after announcing plans to present five papers at the upcoming Annual Meeting of the American Brachytherapy Society (ABS).

"IsoRay is pleased to once again participate at the ABS annual meeting,” said CEO Dwight Babcock. “At this venue, thought leaders including Drs. Ron Benoit, Sushil Beriwal and Ryan P. Smith of the University of Pittsburg Medical Center (UPMC), Drs. Bhupesh Parashar and Gabriella Wernicke of Weill Cornell Medical College, and Dr. Brian Moran of the Chicago Prostate Center will be panelists or present their papers documenting their experiences and success in using our products.

IsoRay’s stock gapped up 17.3 percent to $2.58 a share with the opening bell and climbing to a high of $2.79 a share in choppy trading before pulling back to just under $2.60 by late morning. Shares were moving at a brisk clip, with over 17 million changing hands before noon against an average daily volume of just over 11.5 million.

The fact that the mere announcement of these presentations was enough to spike the stock like this would come as a surprise were it not for the wild March IsoRay just went through. The stock was trading at less than $1 a share until a March 14 article on Seeking Alpha prompted a boot to over $1.10 a share. However, it was five days later on March 19 when shares positively exploded following the announcement that IsoRay’s Cesium-131 brachytherapy had been used to effectively treat an aggressive form of cancer in a pediatric patient.

Since then, IsoRay has seen its volume skyrocket with big price swings on multiple days, including a pullback from 7-year highs after the announcement of a new public offering, then another rebound after the stock appeared to cross over into oversold territory.

The treatment driving IsoRay’s huge month is brachytherapy, or internal radiotherapy, using Cesium-131. It’s a method for radiation treatment of cancer that involves focused radiation through placing the radiation source, in IsoRay’s case a Cesium-131 seed mesh, into the human body surrounding the affected area.

However, beyond the science and fundamentals, it’s important to note that IsoRay appears to have become a popular momentum stock that’s closely watched by traders. Its average daily volume is more than 20 percent of its total float, and the stock’s heavy trading and incredible volatility is precisely what traders on the hunt for a quick play are looking for.

As such, the fact that the 14-day stochastic RSI for IsoRay’s stock had fallen below 0.20 is notable prior to the day’s surge. Stochastic RSI is popular with traders, and a level below 0.20 is traditionally viewed as oversold territory. And, while the 14-day RSI remains relatively high, it’s stayed under 70, the level above which stocks are traditionally viewed as being overbought, since its pull-back started on March 22.

So, with a news item to act as a catalyst and a buy signal from a key technical factor, it appears as though Wall Street’s favorite momentum play has struck again. Investors anticipating another big spike following the presentations at the conference, which takes place this weekend, could be trying to get in ahead of any new data that could be released, and it seems possible this action is getting buoyed by traders who, noting the stochastic RSI and the upward momentum, are jumping onto the big gains.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Liked What You Read? Join Equities.com and Connect With Your Favorite Financial Experts FOR FREE! Members of Equities.com gain access to our leading financial news and content, active social investment community, proprietary research tools including the 2014 Small-Cap Stars, E.V.A. reports and more.

Results for ISR
brian sweetheart
1 Jul 15 17:15:06
Voted top trading group. http://t.co/5eVXN8RJLp Related: $ISR $HK $NUGN $OXIS $HL $OIBR $RGSE
Mark Trader
1 Jul 15 17:06:06
100% non-compensated picks at http://t.co/R6BGOmTldH. That is awesome. Related: $GGB $NBS $GDP $FCEL $ISR $OXIS
Sentiquant
1 Jul 15 15:00:04
#sentishiftup $WFC $EEM $T $NETE $BLUE $HIMX $QLD $ISR $IBM $ESPR #sentiquant 20150701 18:00:06:479
WatchTheFunds
1 Jul 15 11:55:02
$ISR Institutional ownership up 17.5% Q/Q, with 465,542 net purchase http://t.co/lqRBEQQjHb http://t.co/11Z3UIMHN8
x54389
1 Jul 15 09:04:02
$TST $ISR SPECULATION-Activist Update -Day 9-OL to The Street Inc BoD-No Action(s)-Pg 1of5 https://t.co/eldPcBOlUe http://t.co/Z8gxtUptTj
x54389
1 Jul 15 09:03:40
$TST $ISR SPECULATION-Activist Update -Day 9-OL to The Street Inc BoD-No Action(s)-Pg 2of5 https://t.co/eldPcBOlUe http://t.co/lUq1wVUoW0
x54389
1 Jul 15 09:03:06
$TST $ISR SPECULATION-Activist Update -Day 9-OL to The Street Inc BoD-No Action(s)-Pg 3of5 https://t.co/eldPcBOlUe http://t.co/0XZZO44fDR
x54389
1 Jul 15 09:02:29
$TST $ISR SPECULATION-Activist Update -Day 9-OL to The Street Inc BoD-No Action(s)-Pg 4of5 https://t.co/eldPcBOlUe http://t.co/mXfX3Mp9wp
x54389
1 Jul 15 09:01:49
$TST $ISR SPECULATION-Activist Update -Day 9-OL to The Street Inc BoD-No Action(s)-Pg 5of5 https://t.co/eldPcBOlUe http://t.co/amU1rjwja4
x54389
1 Jul 15 05:28:02
$TST $ISR -SPECULATION- ...Possible business risk thesis in reference to The Street Inc... https://t.co/0w1kl0ONMs http://t.co/8a467icK8w
Arsenal
1 Jul 15 05:09:07
@parabol128 EXACTLY, thats why I am ss biased. Kinda like how after $PBMD people where excited by $ISR but it popped and faded all day
StockNewsWires
30 Jun 15 13:59:03
$ISR: IsoRay Investors Alert: Lieff Cabraser Reminds Investors of July 21 ...: http://t.co/w1uaLZ9l83
Debra Borchardt
30 Jun 15 12:42:10
RT @adamfeuerstein: Naturally, Karan is a member of the @StockTwits biotech trading community. Makes perfect sense. $ISR http://t.co/Xjxkzt…
John Anderson
30 Jun 15 12:33:11
RT @adamfeuerstein: Naturally, Karan is a member of the @StockTwits biotech trading community. Makes perfect sense. $ISR http://t.co/Xjxkzt…
Adam Feuerstein
30 Jun 15 12:30:56
Naturally, Karan is a member of the @StockTwits biotech trading community. Makes perfect sense. $ISR http://t.co/XjxkztsCJs
x54389
30 Jun 15 12:14:08
$TST $ISR - June 30, 2015 - Updated Correspondence relating to IsoRay Inc. Activism https://t.co/qCH8MH4NN5 http://t.co/oHePMeiDCo
BioInvestor
30 Jun 15 07:48:08
@BioInvestor2013 http://t.co/MQtPDqw5o6 J.P.Morgan Call $blrx with a conservative $5 we expect a Big UPGRADE soon $cprx $iSR $ino
x54389
30 Jun 15 06:43:26
$ISR $TST FACT - StockTwits Sentiment on IsoRay is 1% Bearish and 99 % Bullish >>>>>>>>>>>>>>>>>>>>>>>>>>>>>> BULLISH http://t.co/1KE5IiRAeQ
x54389
30 Jun 15 06:38:47
$ISR FACT - StockTwits Sentiment on IsoRay is 1% Bearish and 99 % Bullish >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> BULLISH
Mr Bentley Onelly
30 Jun 15 04:14:52
$ISR IsoRay's Cesium-131 Selected by Chicago Prostate Cancer Center for Use in the Launch of a Study of the Focal Treatment of Prostate
WatchTheFunds
29 Jun 15 17:59:02
$ISR Institutional ownership up 17.5% Q/Q, with 465,542 net purchase http://t.co/lqRBEQQjHb http://t.co/vuAyRMsyq9
Jason Peacock
29 Jun 15 17:18:38
RT @wWFinancial: $ISR @Isoray Dr. Moran:"This should be the goal of any #cancer therapy: to eradicate the malignancy while not impairing q…
Wall Street
29 Jun 15 12:45:32
The Penny Stock Superstar team voted #1 OTC trading group. http://t.co/cQ0lLTokka Related: $OREX $AGTK $CHGG $ISR $ARRY
Worldwide Financial
29 Jun 15 11:55:26
$ISR @Isoray #ProstateCancerTreatment #biotech http://t.co/dbxOPusBUv
RICHARD-BSIGROUP
29 Jun 15 11:53:13
RT @wWFinancial: @Isoray successful evaluation of its #quality management system. $ISR received ISO 13485 certificate, awarded by BSI http…
Stock Rocket
29 Jun 15 11:46:02
Intersting article about a new stock pick site. http://t.co/nU3hf3Cf56. Related: $RXMD $ECIG $BRNW $BAA $EBML $ISR
Wall Street
29 Jun 15 11:36:24
The Penny Stock Superstar team voted #1 OTC trading group. http://t.co/cQ0lLTokka Related: $OREX $AGTK $CHGG $ISR $ARRY
Worldwide Financial
29 Jun 15 11:03:40
$ISR @Isoray Dr. Moran:"This should be the goal of any #cancer therapy: to eradicate the malignancy while not impairing quality of life."
Worldwide Financial
29 Jun 15 10:38:54
$ISR @Isoray Seeds of hope implanted in brain cancer patient http://t.co/JMggGqVcuR
Worldwide Financial
29 Jun 15 10:16:31
$ISR #ProstateCancer focal therapy aim to eliminate the targeted cancer with less side effects than whole gland treatment. #biotech #medtech
JDizzle
29 Jun 15 10:15:51
RT @wWFinancial: $ISR: Dr. Brian J. Moran has initiated a study of focal prostate #cancer treatment using #Cesium-131 #brachytherapy. #biot…
Worldwide Financial
29 Jun 15 10:04:30
$ISR: Dr. Brian J. Moran has initiated a study of focal prostate #cancer treatment using #Cesium-131 #brachytherapy. #biotech #DigitalHealth
Worldwide Financial
29 Jun 15 09:33:29
$ISR https://t.co/wesTNBh9MJ
Worldwide Financial
29 Jun 15 09:31:15
RT @WatchTheFunds: $ISR Institutional ownership up 17.5% Q/Q, with 465,542 net purchase http://t.co/lqRBEQQjHb http://t.co/bXqsWg1Kus
EyeBeThere
29 Jun 15 09:02:54
RT @Isoray: Cs-131 Use In Prostate Focal Treatment Hopes To Minimize Side Effects & Improve Patient Quality Of Life http://t.co/VtOCOAHwC2 …
Worldwide Financial
29 Jun 15 08:36:34
$ISR Cesium-131 in Prostate Focal Cancer Treatment Hopes to Minimize Side Effects Improve Patient Quality of Life: http://t.co/Qoy0J0B458
Isoray
29 Jun 15 08:27:40
Cs-131 Use In Prostate Focal Treatment Hopes To Minimize Side Effects & Improve Patient Quality Of Life http://t.co/VtOCOAHwC2 $isr @isoray
WatchTheFunds
29 Jun 15 08:00:02
$ISR Institutional ownership up 17.5% Q/Q, with 465,542 net purchase http://t.co/lqRBEQQjHb http://t.co/bXqsWg1Kus
Dr.Anonymous
29 Jun 15 06:29:46
RT @SleemStockPicks: Primary watch list today: $JNUG $SRPT $PTX $JUNO $PMCB $BLDP $ONVO $SYN $MCRB $ISR $TVIX
Time=Best Stock
29 Jun 15 06:18:39
RT @SleemStockPicks: Primary watch list today: $JNUG $SRPT $PTX $JUNO $PMCB $BLDP $ONVO $SYN $MCRB $ISR $TVIX
Faris Sleem
29 Jun 15 06:08:03
Primary watch list today: $JNUG $SRPT $PTX $JUNO $PMCB $BLDP $ONVO $SYN $MCRB $ISR $TVIX
BreakingStocksNews
29 Jun 15 05:49:04
$ISR: IsoRay's Cesium-131 Selected by Chicago Prostate Cancer Center ...: http://t.co/FvA3AstoYM
Time=Best Stock
29 Jun 15 05:45:42
RT @SleemStockPicks: $ISR news - http://t.co/ijysbTnRe1
Faris Sleem
29 Jun 15 05:45:21
$ISR news - http://t.co/ijysbTnRe1
Time=Best Stock
29 Jun 15 05:44:11
RT @WrigleyTom: $ISR 1.52 IsoRay's Cesium-131 Selected by Chicago Prostate Cancer Center for Use in the Launch of a Study o... http://t.…
Tom Wrigley
29 Jun 15 05:34:29
$ISR 1.52 IsoRay's Cesium-131 Selected by Chicago Prostate Cancer Center for Use in the Launch of a Study o... http://t.co/UuX9coOBUW
Gehrig Leary
29 Jun 15 05:32:00
RT @VexTrades: $ISR Cesium-131 Selected by Chicago Prostate Cancer Center for Use in the Launch of a Study of the Focal Treatment of Prosta…
Brandon Hayward
29 Jun 15 05:30:53
$ISR Cesium-131 Selected by Chicago Prostate Cancer Center for Use in the Launch of a Study of the Focal Treatment of Prostate Cancer.
TimeForGrowth
29 Jun 15 03:39:02
$ISR: Wall Street analysts bullish on ISR's earnings growth: http://t.co/i6hjJP3KG3 http://t.co/wqZSIEFJ6y
Mike
28 Jun 15 15:41:40
New trading rule for $ISR http://t.co/sndi5Ra5VL
				
				
By  +Follow April 1, 2014 6:16AM
Share:

Comments

 

blog comments powered by Disqus

 

 Today's Must Reads

Microsegmentation: The Future of Cybersecurity?


How this Playboy Playmate Became a Better Stock Trader Than You

Long Term Rates Are On The Up…What’s Next?

The Modern Web: So Many Ways to Invest in Wireless Mobile Stocks

It's Time for the Rest of the Country to Legalize Weed

 

Do you expect a 10% correction by the end of 2015? in Equities.com Polls on LockerDome

About us

Equities.com is an advanced financial data portal and social network designed to connect self-directed investors with the world’s most innovative startup and small cap companies. Through our in-depth coverage of small cap markets, comprehensive research and stock valuation reports, state of the art issuer products, and world class events, Equities.com provides the social tools and insight that drive tomorrow’s investment relationships and opportunities.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.

Login or Register

LOG IN